Brief: Kane Biotech And Dechra Veterinary Products Expand Exclusive License And Distribution Agreement To Include South America
16/10/2019 12:01
Oct 16 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH AND DECHRA VETERINARY PRODUCTS EXPAND
EXCLUSIVE
LICENSE AND DISTRIBUTION AGREEMENT TO INCLUDE SOUTH AMERICA
* KANE BIOTECH INC - TERMS OF AGREEMENT ARE CONFIDENTIAL
* KANE BIOTECH- CO WILL RECEIVE UPFRONT PAYMENT UPON 1ST
COMMERCIAL SALE OF VETRADENT IN BRAZIL, ONGOING ROYALTY ON NET
VETRADENT SALES IN S. AMERICA
* KANE BIOTECH - CO & UNIT OF DECHRA PHARMACEUTICALS PLC
ANNOUNCED
EXPANSION OF 10-YEAR EXCLUSIVE LICENSE AND DISTRIBUTION
AGREEMENT TO INCLUDE S. AMERICA
Source text for Eikon: ID:nGNX4qDG9c
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update